1ATAC Trialists' Group. Results of the ATAC (Arimidex, "Famoxifen, alone or in combination) after completion of 5 years' adjuvant treatmentfor breast cancer. Lancet 2005, 365:60.
1[2]Nahboltz J M, Buzdar A, Pollak M, et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol,2000, 18 (22) :3758
2[3]Bonneterre J, Thurliman B, Robertson J F R, et al. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study. J Clin Oncol, 2000, 18 (22) :3748
3[5]Patrick Therasse, Susan G, Arbuck, et al. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Insitute, 2000, 92 (3) : 205
4[8]Buzdar A, Jonat W, Howell A, et al. Significant improved survival with arimidex (anastrozole) vs megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase trials. J Clin Oncol, 1996, 14:2000
5[9]Buzdar A, Jonat W, Howell A, et al. Anatrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: Results of a survial update based on a combined analysis of data from two, mature phase Ⅲ trials.Cancer, 1998, 83:1142
6[10]Taylor CW, Green S, Dalton WS, et al. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer. J ClinOncol, 1998, 16 (3) :993
7[11]Michaud LB, Buzdar Au. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer. Drugs Aging, 2000, 16 (4) :261
8[12]Milla-Santos A, Milla L, Portella J, et al. A randomized trial of goserelin (zolade.xTm ) + tamoxifen versus goserelin + anastrozole (arimidexTm) in pre/perimenopausal patients with hormone dependent advanced breast cancer. Breast Cancer Res Treat, 2000:64 (1) :Abstract 173
